Lesions hyper- to isointense to surrounding liver in the hepatobiliary phase of gadoxetic acid-enhanced MRI

被引:1
作者
Furumaya, Alicia [1 ,2 ]
Willemssen, Francois E. J. A. [3 ]
Miclea, Razvan L. [4 ]
Haring, Martijn P. D. [5 ]
de Haas, Robbert J. [6 ]
Feshtali, Shirin [7 ]
Vanhooymissen, Inge J. S. [2 ,8 ]
Bos, Daniel [3 ,9 ]
de Man, Robert A. [10 ]
Ijzermans, Jan N. M. [11 ]
Erdmann, Joris I. [1 ,2 ]
Verheij, Joanne [2 ,12 ]
Doukas, Michail C. [13 ]
van Delden, Otto M. [2 ,14 ]
Thomeer, Maarten G. J. [3 ]
机构
[1] Univ Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands
[2] Canc Ctr Amsterdam, Amsterdam, Netherlands
[3] Erasmus Univ, Dept Radiol & Nucl Med, Erasmus MC, Rotterdam, Netherlands
[4] Maastricht Univ, Dept Radiol & Nucl Med, Med Ctr, Maastricht, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands
[7] Leiden Univ, Dept Radiol, Leiden UMC, Leiden, Netherlands
[8] Vrije Univ Amsterdam, Dept Radiol, Amsterdam UMC, Amsterdam, Netherlands
[9] Erasmus Univ, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands
[10] Erasmus Univ, Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[11] Erasmus Univ, Dept Surg, Erasmus MC, Med Ctr, Rotterdam, Netherlands
[12] Univ Amsterdam, Dept Pathol, Amsterdam UMC, Amsterdam, Netherlands
[13] Erasmus Univ, Dept Pathol, Erasmus MC, Med Ctr, Rotterdam, Netherlands
[14] Univ Amsterdam, Dept Radiol, Amsterdam UMC, Amsterdam, Netherlands
关键词
Magnetic resonance imaging; Liver cell adenoma; Hepatocellular carcinoma; Focal nodular hyperplasia; Gadolinium DTPA; FOCAL NODULAR HYPERPLASIA; HEPATOCELLULAR ADENOMA; GADOBENATE DIMEGLUMINE; QUANTITATIVE-ANALYSIS; EXTERNAL VALIDATION; DIAGNOSTIC-VALUE; CARCINOMA; DIFFERENTIATION; PATTERNS; FEATURES;
D O I
10.1007/s00330-024-10829-x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives Hyper- or isointensity in the hepatobiliary phase (HBP) of gadoxetic acid-enhanced MRI has high specificity for focal nodular hyperplasia (FNH) but may be present in hepatocellular adenoma and carcinoma (HCA/HCC). This study aimed to identify imaging characteristics differentiating FNH and HCA/HCC.Materials and methods This multicenter retrospective cohort study included patients with pathology-proven FNH or HCA/HCC, hyper-/isointense in the HBP of gadoxetic acid-enhanced MRI between 2010 and 2020. Diagnostic performance of imaging characteristics for the differentiation between FNH and HCA/HCC were reported. Univariable analyses, multivariable logistic regression analyses, and classification and regression tree (CART) analyses were conducted. Sensitivity analyses evaluated imaging characteristics of B-catenin-activated HCA.Results In total, 124 patients (mean age 40 years, standard deviation 10 years, 108 female) with 128 hyper-/isointense lesions were included. Pathology diagnoses were FNH and HCA/HCC in 64 lesions (50%) and HCA/HCC in 64 lesions (50%). Imaging characteristics observed exclusively in HCA/HCC were raster and atoll fingerprint patterns in the HBP, sinusoidal dilatation on T2-w, hemosiderin, T1-w in-phase hyperintensity, venous washout, and nodule-in-nodule partification in the HBP and T2-w. Multivariable logistic regression and CART additionally found a T2-w scar indicating FNH, less than 50% fat, and a spherical contour indicating HCA/HCC. In our selected cohort, 14/48 (29%) of HCA were B-catenin activated, most (13/14) showed extensive hyper-/isointensity, and some had a T2-w scar (4/14, 29%).Conclusion If the aforementioned characteristics typical for HCA/HCC are encountered in lesions extensively hyper- to isointense, further investigation may be warranted to exclude B-catenin-activated HCA.Clinical relevance Hyper- or isointensity in the HBP of gadoxetic acid-enhanced MRI is specific for FNH, but HCA/HCC can also exhibit this feature. Therefore, we described imaging patterns to differentiate these entities.Key Points . . .
引用
收藏
页码:7661 / 7672
页数:12
相关论文
共 42 条
[1]   HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI [J].
Auer, Timo Alexander ;
Walter-Rittel, Thula ;
Geisel, Dominik ;
Schoening, Wenzel ;
Schmelzle, Moritz ;
Mueller, Tobias ;
Sinn, Bruno ;
Denecke, Timm ;
Hamm, Bernd ;
Fehrenbach, Uli .
BMC MEDICAL IMAGING, 2021, 21 (01)
[2]   Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? [J].
Auer, Timo Alexander ;
Fehrenbach, Uli ;
Grieser, Christian ;
Penzkofer, Tobias ;
Geisel, Dominik ;
Schmelzle, Moritz ;
Mueller, Tobias ;
Blaeker, Hendrik ;
Seehofer, Daniel ;
Denecke, Timm .
EUROPEAN RADIOLOGY, 2020, 30 (06) :3497-3506
[3]   Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging [J].
Ba-Ssalamah, Ahmed ;
Antunes, Celia ;
Feier, Diana ;
Bastati, Nina ;
Hodge, Jacqueline C. ;
Stift, Judith ;
Cipriano, Maria A. ;
Wrba, Friedrich ;
Trauner, Michael ;
Herold, Christian J. ;
Caseiro-Alves, Filipe .
RADIOLOGY, 2015, 277 (01) :104-113
[4]   Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma [J].
Bilreiro, Carlos ;
Soler, Juan Carlos ;
Ayuso, Juan R. ;
Caseiro-Alves, Filipe ;
Ayuso, Carmen .
RADIOLOGIA MEDICA, 2021, 126 (11) :1379-1387
[5]   Immunohistochemical Markers on Needle Biopsies Are Helpful for the Diagnosis of Focal Nodular Hyperplasia and Hepatocellular Adenoma Subtypes [J].
Bioulac-Sage, Paulette ;
Cubel, Gaelle ;
Taouji, Said ;
Scoazec, Jean-Yves ;
Leteurtre, Emmanuelle ;
Paradis, Valerie ;
Sturm, Nathalie ;
Jeanne Tran Van Nhieu ;
Wendum, Dominique ;
Bancel, Brigitte ;
Ramos, Jeanne ;
Paraf, Francois ;
Saint Paul, Marie Christine ;
Michalak, Sophie ;
Fabre, Monique ;
Guettier, Catherine ;
Le Bail, Brigitte ;
Zucman-Rossi, Jessica ;
Balabaud, Charles .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (11) :1691-1699
[6]   Mosaic architecture of hepatocellular carcinoma [J].
Cannella, Roberto ;
Furlan, Alessandro .
ABDOMINAL RADIOLOGY, 2018, 43 (07) :1847-1848
[7]  
Castan A., 2017, HEPATOMA RES, V3, P1, DOI [10.20517/2394-5079.2015.62, DOI 10.20517/2394-5079.2015.62]
[8]   Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients [J].
Chernyak, Victoria ;
Fowler, Kathryn J. ;
Kamaya, Aya ;
Kielar, Ania Z. ;
Elsayes, Khaled M. ;
Bashir, Mustafa R. ;
Kono, Yuko ;
Do, Richard K. ;
Mitchell, Donald G. ;
Singal, Amit G. ;
Tang, An ;
Sirlin, Claude B. .
RADIOLOGY, 2018, 289 (03) :816-830
[9]   Hepatocellular Carcinoma: Imaging Patterns on Gadoxetic Acid-enhanced MR Images and Their Value as an Imaging Biomarker [J].
Choi, Jin Woo ;
Lee, Jeong Min ;
Kim, Soo Jin ;
Yoon, Jeong-Hee ;
Baek, Jee Hyun ;
Han, Joon Koo ;
Choi, Byung Ihn .
RADIOLOGY, 2013, 267 (03) :776-786
[10]   EASL Clinical Practice Guidelines on the management of benign liver tumours [J].
Colombo, Massimo ;
Forner, Alejandro ;
Ijzermans, Jan ;
Paradis, Valerie ;
Reeves, Helen ;
Vilgrain, Valerie ;
Zucman-Rossi, Jessica .
JOURNAL OF HEPATOLOGY, 2016, 65 (02) :386-398